title: Severely worsening dyspnea after initiation of macitentan therapy for pulmonary arterial hypertension.
authors.affiliation: Department of Cardiology, Kantonsspital St. Gallen, St. Gallen, Switzerland. Electronic address: Micha.maeder@kssg.ch.
authors.forename: Micha T
authors.initials: MT
authors.lastname: Maeder
authors.affiliation: Department of Pulmonary Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland.
authors.forename: Rebekka
authors.initials: R
authors.lastname: Kleiner
authors.affiliation: Department of Cardiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
authors.forename: Daniel
authors.initials: D
authors.lastname: Weilenmann
mesh_terms: D000368:Aged; D004417:Dyspnea / Q000139:chemically induced* / Q000503:physiopathology; D065130:Endothelin A Receptor Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000503:physiopathology; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects*; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D065130:Endothelin A Receptor Antagonists; D011743:Pyrimidines; D013449:Sulfonamides; C533860:macitentan
keywords: Left ventricular diastolic function; Macitentan; Pulmonary hypertension